Is Aileron Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: ALRN) stock is to Strong Buy ALRN stock.
Out of 1 analyst, 1 (100%) are recommending ALRN as a Strong Buy, 0 (0%) are recommending ALRN as a Buy, 0 (0%) are recommending ALRN as a Hold, 0 (0%) are recommending ALRN as a Sell, and 0 (0%) are recommending ALRN as a Strong Sell.
What is ALRN's forecast return on equity (ROE) for 2023-2025?
(NASDAQ: ALRN) forecast ROE is -275.76%, which is considered weak.
What is ALRN's Price Target?
According to 1 Wall Street analyst that have issued a 1 year ALRN price target, the average ALRN price target is $9.00, with the highest ALRN stock price forecast at $9.00 and the lowest ALRN stock price forecast at $9.00.
The Wall Street analyst predicted that Aileron Therapeutics's share price could reach $9.00 by Dec 1, 2024. The average Aileron Therapeutics stock price prediction forecasts a potential upside of 291.3% from the current ALRN share price of $2.30.
What is ALRN's forecast return on assets (ROA) for 2023-2025?
(NASDAQ: ALRN) forecast ROA is -240.84%, which is lower than the forecast US Biotechnology industry average of 10.9%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.